Venus Concept

What Venus Concept does

Venus Concept Inc. is a Toronto-based medical aesthetic device company (founded 2009) that develops, manufactures, and globally distributes non-invasive energy-based platforms for body contouring, skin rejuvenation, hair removal, and hair restoration. The product portfolio is organized into three categories—Body (Venus Bliss MAX, Venus Bliss, Venus Legacy, Venus Nova), Face & Skin (Venus Versa, Venus Versa Pro, Venus Viva MD, TriBella, Venus Glow), and Hair (ARTAS iXi, NeoGraft, Venus Velocity, Venus Epileve)—spanning diode laser, IPL, NanoFractional RF, proprietary (MP)² (Multi-Polar RF + PEMF), VariPulse, FlexMAX EMS, and robotic AI-assisted modalities. Devices are FDA-cleared, Health Canada-licensed, and CE-marked across major indications and are sold to medical spas, dermatologists, plastic surgeons, and hair transplant physicians through an enterprise field-sales model staffed by Practice Development Managers who deliver clinical training, marketing support, technical service, and financial planning. The hardware-sale business model is differentiated by a zero-consumable, zero-usage-fee structure designed to simplify provider ROI, supported by an IoT data layer branded "Aesthetic Intelligence" and an installed base of 12,000+ units across 60+ countries (11 direct markets) performing 10 million+ treatments annually. The company traded publicly on NASDAQ as VERO before being taken private on March 30, 2026 in a short-form merger with funds managed by Madryn Asset Management at $0.04 per share, following a $1.5 million pre-merger common stock issuance to Madryn for working-capital support.

Name

Venus Concept

Legal name

Venus Concept Inc.

Website

https://venus.ai

Company type

Private

Founded year

2009

Operating status

Operating

Headcount range

251–500 employees

Short description

Venus Concept Inc. is a Toronto-based medical aesthetic device company that designs, manufactures, and globally distributes FDA-cleared, CE-marked energy-based platforms for body contouring, skin rejuvenation, hair removal, and robotic hair restoration, sold to medical spas, dermatologists, plastic surgeons, and hair transplant physicians via direct enterprise field sales.

Ownership category

akta.pro rank

Product category

Medical Aesthetic Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical and Medical Instrument Manufacturing (339112)

SIC

Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Energy-Based Surgical Devices (Electrosurgery, RF, Ultrasonic, Laser) (HLAHADAC)

Keywords

• Medical aesthetic devices
• Body contouring systems
• Skin resurfacing equipment
• Robotic hair restoration
• Energy-based aesthetics

Headquarters

HQ city

Toronto

HQ country

Canada

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Operations, Personnel, Marketing or Sales, Supply Chain

Revenue model

1. Medical Aesthetic Device Sales: Venus Concept generates revenue through the sale of medical aesthetic equipment including body contouring devices (Venus Bliss MAX, Venus Bliss, Venus Legacy), multi-treatment platforms (Venus Versa, Venus Versa Pro), skin resurfacing devices (Venus Viva MD), and hair restoration systems (ARTAS iXi, NeoGraft). The company sells directly to medical spas, dermatologists, plastic surgeons, and hair transplant physicians through enterprise field sales with practice development support.
2. Treatment Services and Support: Revenue is supported by ongoing clinical training, technical support, and practice development services that help clinics maximize the profitability of their Venus devices, creating recurring engagement and account management relationships.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Core offering

Venus Concept designs, develops, manufactures, and sells non-invasive energy-based medical aesthetic devices — including body contouring systems (Venus Nova, Venus Bliss MAX, Venus Bliss, Venus Legacy), face and skin rejuvenation platforms (Venus Versa Pro, Venus Versa, Venus Viva MD, Venus Glow), hair restoration systems (ARTAS iXi, NeoGraft), and diode-laser hair removal devices (Venus Velocity, Venus Epileve). The portfolio combines proprietary (MP)² Multi-Polar RF + PEMF, NanoFractional RF, IPL, diode laser, EMS, and AI-enabled robotics. Devices are sold directly to medical spas, dermatologists, plastic surgeons, and hair transplant physicians with bundled clinical training and Practice Development support.

Product overview

Venus Concept is a medical aesthetic device company offering a comprehensive portfolio of non-invasive aesthetic treatment platforms and specialized devices. The product architecture is organized into three main categories: Body (fat reduction, muscle stimulation, skin tightening), Face & Skin (skin resurfacing, wrinkle reduction, photorejuvenation, acne treatment), and Hair (restoration and removal). The portfolio includes multi-treatment platforms (Venus Versa™ Pro, Venus Versa™, Venus Legacy™) that serve as core systems with multiple applicator technologies, along with specialized devices for specific treatments. Hair restoration offerings include the robotic ARTAS® iXi system and the automated FUE NeoGraft® system. Body contouring devices include the Venus Bliss MAX™ (3-in-1 fat/muscle/skin) and Venus Bliss™ (laser lipolysis). Skin resurfacing is led by Venus Viva™ MD with NanoFractional RF technology. The company operates in over 60 countries with presence in 11 direct markets, performing over 10 million treatments annually worldwide.

Differentiator

Problem solved

Functional benefit

Brands

• ARTAS® iXi: Robotic hair transplant system - the world's first intelligent hair transplant platform utilizing robotic and artificial intelligence technology with 44-micron resolution stereoscopic vision and 7-axis KUKA robotic arm.
• NeoGraft®
• Venus Velocity™
• Venus Epileve™
• Venus Bliss MAX™
• Venus Bliss™
• Venus Legacy™
• Venus Versa™
• Venus Versa™ Pro
• Venus Viva™ MD
• TriBella™
• Venus Nova

Products and services

• Venus Nova Advanced 3-in-1 body shaping platform combining EMS muscle stimulation, proprietary (MP)² Multi-Polar RF + PEMF, and VariPulse™ technology for body sculpting and skin rejuvenation, with integrated Aesthetic Intelligence for data-driven utilization insights. Targeted at clinics and aesthetic practices.
• Venus Bliss MAX™ Advanced 3-in-1 body shaping workstation combining 1064nm diode laser for non-invasive lipolysis, FlexMAX EMS for muscle conditioning, and (MP)² technology for skin and cellulite reduction. FDA cleared and Health Canada licensed for non-invasive lipolysis of abdomen, flanks, back, and thighs.
• Venus Bliss™ Non-invasive laser lipolysis machine using 1064 nm diode laser for fat reduction in abdomen and flanks, combined with (MP)² applicator for skin and cellulite treatment. FDA cleared and CE Marked.
• Venus Legacy™ Full body and face solution combining Multi-Polar RF and PEMF (MP)² with VariPulse™ technology for non-surgical cellulite reduction and wrinkle reduction. FDA cleared and CE Marked.
• Venus Versa™ Multi-treatment platform combining SmartPulse™ IPL, SmartScan™ NanoFractional RF, and (MP)² technology for photorejuvenation, acne treatment, hair removal, skin resurfacing, and wrinkle reduction. FDA cleared and CE Marked.
• Venus Versa™ Pro Advanced multi-treatment platform with 10 applicators and 25 treatments, offering IPL, NanoFractional RF, and (MP)² technologies with enhanced energy output up to 124 mJ/pin for more severe skin concerns. Hosts the TriBella™ tri-modality facial rejuvenation treatment.
• Venus Viva™ MD NanoFractional Radio Frequency skin resurfacing device with SmartScan™ technology for customizable ablation and coagulation patterns; safe for all Fitzpatrick skin types I–VI with minimal downtime. FDA cleared and CE Marked.
• Venus Glow™ Skin renewal system included in the Venus face and skin device portfolio, designed to boost the profitability of aesthetic treatments.
• ARTAS® iXi World's first intelligent robotic hair transplant system utilizing advanced AI and a 7-axis KUKA robotic arm with 44-micron stereoscopic vision for precise follicular unit extraction without linear scarring. FDA cleared (Class II), CE Marked, and Health Canada licensed.
• NeoGraft® Automated Follicular Unit Extraction (FUE) hair transplant system with pneumatic motor and smart drive torque technology, providing minimally invasive procedures with no linear scar and fast patient recovery. FDA cleared and CE Marked.
• Venus Velocity™ Diode laser hair removal device with 800 nm wavelength, real-time cooling system, and dual-mode PULSE/SLIDE operation for fast, comfortable treatments safe for all Fitzpatrick skin types including tanned skin. FDA cleared and CE Marked.
• Venus Epileve™ Portable tabletop diode laser hair removal device with gold-standard efficacy and safety for hair removal, permanent hair reduction, treatment of pseudofolliculitis barbae across all skin types, and hirsutism. CE Marked.

Quantifiable outcome

• Up to 41% reduction in adipose layer thickness
• +7 more outcomes

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature8 records

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• InMode: InMode is a leading medical aesthetic device company offering RF-based platforms (e.g., Morpheus8, BodyTite) for body contouring, skin remodeling, and hair treatments. It directly competes with Venus Concept across many of the same clinical indications and provider segments.
• BTL Industries: BTL markets EmSculpt (EMS-based muscle building), EmSculpt NEO (EMS+RF), and other body-contouring devices. It is a primary direct competitor in non-invasive body shaping and muscle conditioning, directly overlapping with Venus Bliss MAX and FlexMAX.
• Cutera: Cutera is a US-based medical aesthetic device company with a portfolio spanning laser hair removal, IPL photorejuvenation, RF microneedling, and body sculpting, overlapping directly with Venus's Versa, Velocity, and body-shaping platforms.
• Cynosure (Hologic): Cynosure, now part of Hologic, develops energy-based aesthetic and medical devices including hair removal lasers, RF body contouring, and skin revitalization platforms, making it a direct competitor across multiple Venus product categories.
• Alma Lasers: Alma Lasers is a global developer of laser, RF, ultrasound, and IPL-based aesthetic devices serving medical spas, dermatologists, and plastic surgeons, with substantial overlap to Venus's product portfolio in hair removal, skin resurfacing, and body contouring.
• Solta Medical (Bausch Health): Solta Medical, owned by Bausch Health, markets Thermage (RF skin tightening), Fraxel (fractional laser), Clear+Brilliant, and Liposonix, directly competing with Venus Legacy, Venus Viva MD, and Venus Bliss in energy-based aesthetics.
• Lumenis: Lumenis is a global energy-based medical device company with leading positions in aesthetic laser, IPL, and RF systems, competing head-to-head with Venus in hair removal, photorejuvenation, and skin resurfacing segments.
• Candela: Candela (now part of Apyx Medical after the aesthetics business was sold) is a global aesthetic device maker with strong laser and IPL platforms, including GentleLase and GentleYag, directly competing with Venus Velocity and Venus Versa IPL.
• Sciton: Sciton develops high-end laser and light-based aesthetic and medical platforms (BBL, Halo, Joule) widely used by dermatologists and plastic surgeons, overlapping with Venus Versa, Venus Viva MD, and the company's skin rejuvenation portfolio.

Broad incumbents

• Galderma (Galderma Aesthetics): Galderma is a global dermatology and aesthetics incumbent with a broad portfolio of injectables, skincare, and is expanding into device-based aesthetics. While primarily an injectable-focused incumbent, it competes for share of clinic spend and patient flow alongside Venus's energy-based devices.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xtwitter.com/venusconcept
• LinkedInlinkedin.com/company/venus-concept

Compliance16 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Venus Concept